Lipitor Cost in South Carolina 2026: Atorvastatin Prices, Medicaid, and Savings Options

At a glance
- Cash price (generic atorvastatin, 30-tab) / ~$10/month at SC retail pharmacies in 2026
- Brand Lipitor list price / ~$280/month before insurance or coupons
- SC Medicaid coverage / Generic atorvastatin covered; brand Lipitor generally not covered
- Compounded atorvastatin (503A) / Legal and available in SC; cost can be $0 to low copay through some telehealth programs
- Telehealth prescribing in SC / Permitted; atorvastatin is a Schedule-exempt oral tablet
- Typical starting dose / 10 to 20 mg once daily; titrated to 40 to 80 mg based on LDL goal
- Key indication / Primary hypercholesterolemia and ASCVD risk reduction
- FDA approval year / 1996 (Lipitor); generics available since 2011
- Most common side effect requiring monitoring / Myopathy; baseline CK and LFT recommended
- GoodRx / SC price range / $9, $14 depending on pharmacy chain and dose
What Is the Cash Price of Atorvastatin in South Carolina in 2026?
Generic atorvastatin costs approximately $10 per month at South Carolina retail pharmacies when purchased without insurance in 2026. That figure applies to the most common doses (10 mg, 20 mg, and 40 mg, 30-tablet supply) at major chains including Walmart, Kroger, and CVS. The 80 mg dose runs slightly higher at some outlets, typically $12, $18 cash. Brand-name Lipitor carries a manufacturer list price near $280 per month, a figure that matters almost exclusively to patients on high-deductible plans early in their benefit year.
Atorvastatin is one of the most prescribed drugs in the United States. The American Heart Association and American College of Cardiology 2019 guideline on the primary prevention of cardiovascular disease identifies high-intensity statin therapy as first-line for patients with atherosclerotic cardiovascular disease (ASCVD) 10-year risk above 20%, and atorvastatin 40 to 80 mg is the most common agent used to meet that threshold [1]. The clinical rationale for keeping access affordable is direct: patients who cannot afford their statin discontinue it. A 2022 analysis published in the Journal of the American College of Cardiology found that cost-related non-adherence to statins was associated with a 12% higher rate of major adverse cardiovascular events over 36 months [2].
The ASCOT-LLA trial (N=10,305) demonstrated that atorvastatin 10 mg reduced fatal and non-fatal myocardial infarction by 36% versus placebo (hazard ratio 0.64 to 95% CI 0.50, 0.83, P<0.001) in hypertensive patients with average cholesterol levels [3]. That magnitude of benefit makes price transparency a genuine public-health concern for South Carolinians.
South Carolina has a higher age-adjusted cardiovascular mortality rate than the national median, according to CDC data [4]. Getting atorvastatin into patients' hands at $10 or less per month is not a luxury consideration.
Does South Carolina Medicaid Cover Atorvastatin?
South Carolina Medicaid (Healthy Connections) covers generic atorvastatin on its preferred drug list for members with qualifying diagnoses, including hyperlipidemia and established ASCVD. Brand Lipitor is not covered without a prior authorization demonstrating medical necessity, and that authorization is rarely approved given the clinical equivalence of the generic. Members should request generic atorvastatin specifically when speaking with their prescriber, because an inadvertent brand prescription can trigger a coverage denial.
As of the current formulary cycle, atorvastatin 10 mg, 20 mg, 40 mg, and 80 mg tablets are all listed as preferred agents under the SC Medicaid preferred drug list, placing them in Tier 1 with a minimal copay (typically $1, $3 per fill for adults) [5]. Medicaid members who are also eligible for Medicare (dual-eligible) access atorvastatin through their Part D plan, where it typically sits in Tier 1 or Tier 2 with a copay under $10 after the Low Income Subsidy is applied.
The FDA's current approved labeling for atorvastatin calcium tablets (NDA 020702) lists indications that map directly to SC Medicaid's covered diagnoses, including primary hypercholesterolemia, mixed dyslipidemia, and prevention of cardiovascular events in adult patients with multiple risk factors [6]. Prescribers documenting one of these indications on the prior authorization form give the claim its best chance of approval.
Children with familial hypercholesterolemia aged 10 and older are also eligible for SC Medicaid-covered atorvastatin. The American Academy of Pediatrics endorses statin initiation in this population when diet modification fails to normalize LDL [7].
Is Compounded Atorvastatin Legal in South Carolina?
Compounded atorvastatin is legal in South Carolina when prepared by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription. No federal or state regulation currently prohibits compounding atorvastatin for an individual patient when a prescriber determines a commercially available product does not meet that patient's clinical needs.
Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies [8]. Under 503A, a pharmacy may compound atorvastatin in a customized dose strength, alternative base, or allergen-free preparation when the prescriber documents clinical rationale. The South Carolina Board of Pharmacy enforces these rules at the state level and requires pharmacies to comply with USP Chapter 795 standards for non-sterile compounding [9].
Where compounding becomes legally ambiguous is 503B outsourcing facilities. Those facilities may not compound atorvastatin speculatively in large batches without a patient-specific order, and atorvastatin is not currently on the FDA's 503B category 1 bulk drug substances list [8]. Telehealth platforms that route atorvastatin through 503A pharmacies remain within federal and South Carolina law, provided each fill carries an individual prescription.
Practically speaking, the compounded route is most relevant for patients who need a dose not commercially available (for example, 5 mg for elderly patients with low body weight), or for patients enrolled in telehealth programs that bundle the medication cost into a subscription fee. Some programs effectively provide compounded generic atorvastatin at no additional per-fill charge.
The FDA warns consumers to verify that any compounding pharmacy holds a valid state license and operates under current good manufacturing practices [8]. The South Carolina Board of Pharmacy maintains a public license-verification tool at scllr.sc.gov.
Which Insurance Plans Cover Lipitor in South Carolina?
Most commercial insurance plans in South Carolina cover generic atorvastatin at Tier 1 or Tier 2 with a copay of $0, $15 per month. Brand Lipitor sits at Tier 3 or Tier 4 on nearly every commercial formulary, producing copays of $40, $100 or more, which is why prescribers should default to generic.
The Affordable Care Act requires non-grandfathered plans to cover preventive medications with an A or B USPSTF rating at no cost sharing. The USPSTF gives a Grade B recommendation to statin use for adults aged 40, 75 who have one or more CVD risk factors and a calculated 10-year CVD event risk of 10% or greater [10]. Under that rule, qualifying patients in South Carolina on compliant commercial plans may pay $0 out of pocket for atorvastatin, even at Tier 2. The USPSTF final recommendation states: "The USPSTF recommends prescribing a statin for the primary prevention of CVD for adults aged 40 to 75 years who have 1 or more CVD risk factors (dyslipidemia, diabetes, hypertension, or smoking) and an estimated 10-year CVD event risk of 10% or greater." [10]
South Carolina's state employee health plan (PEBA) covers generic atorvastatin at a $10 copay for a 90-day supply through mail order as of the 2025 benefit year. Employees should request 90-day fills to reduce per-day cost.
Medicare Part D enrollees in South Carolina should compare plans annually using the Medicare Plan Finder tool. In 2026, atorvastatin appears on Tier 1 of most Part D formularies in the state, with a $0, $7 copay during the initial coverage phase for plans that have implemented the Inflation Reduction Act's $2,000 annual out-of-pocket cap [11].
What Is the Cheapest Way to Get Lipitor in South Carolina?
The cheapest reliable route for most South Carolinians without Medicaid or comprehensive commercial coverage is a cash-pay generic atorvastatin prescription combined with a free discount card such as GoodRx, RxSaver, or the NeedyMeds database. Prices at Walmart and Costco pharmacies in South Carolina cluster around $9 for a 30-tablet supply of atorvastatin 20 mg or 40 mg using these tools.
Pfizer operates a patient assistance program for brand Lipitor called Pfizer RxPathways, which can reduce or eliminate brand cost for patients who meet income thresholds (typically at or below 400% of the federal poverty level and uninsured or underinsured) [12]. However, given that generic atorvastatin is therapeutically identical and costs $10 cash, the brand assistance program is rarely the optimal path.
The NCEP ATP III guidelines and their successors have established that atorvastatin and other statins reduce LDL cholesterol by a mechanism (HMG-CoA reductase inhibition) that is preserved across brand and generic formulations [13]. The FDA requires generic manufacturers to demonstrate bioequivalence within a 80 to 125% confidence interval, making substitution clinically safe [6].
For patients who qualify for South Carolina Medicaid but have not yet enrolled, a navigator through the SC Department of Health and Human Services can complete enrollment within days. During the wait, GoodRx or a similar coupon brings the price to near-Medicaid levels anyway.
Telehealth platforms licensed in South Carolina can write atorvastatin prescriptions sent electronically to any in-state pharmacy. Some platforms bundle the generic drug cost into a monthly membership fee of $15, $30 that covers both the visit and the medication, which can represent savings versus separate physician office visits for patients without insurance.
How Do Atorvastatin Savings Cards Work in South Carolina?
Manufacturer and third-party savings cards reduce out-of-pocket costs at the point of sale for commercially insured and cash-pay patients. They do not work for Medicaid or Medicare beneficiaries.
Pfizer's Lipitor savings card, available at lipitor.com, can reduce brand Lipitor copays to as low as $4 per month for eligible commercially insured patients in South Carolina. The card applies after insurance, covering the gap between what insurance pays and the patient's copay up to a monthly maximum. Patients must be 18 or older, not enrolled in any federal or state government health program, and a US resident [12].
For generic atorvastatin, third-party discount programs (GoodRx, Blink Health, Cost Plus Drugs) function as cash-pay pricing tools rather than insurance. A clinician or pharmacist can verify the current best price for a specific zip code using those platforms' online tools before the patient arrives at the pharmacy. Mark Cuban's Cost Plus Drugs currently lists atorvastatin 20 mg (90 tablets) at approximately $6, which works out to roughly $2 per month for a 30-day supply [14]. South Carolina residents can order through Cost Plus Drugs with a valid prescription sent electronically from any licensed prescriber, including telehealth providers.
The FDA Orange Book confirms multiple generic manufacturers hold approved ANDAs for atorvastatin calcium, sustaining price competition that keeps retail cash prices low [6].
Can I Get a Lipitor Prescription via Telehealth in South Carolina?
Yes. Telehealth prescribing of atorvastatin is permitted in South Carolina. Atorvastatin is not a controlled substance, so no in-person DEA-compliant examination is required. A licensed physician or nurse practitioner credentialed in South Carolina can evaluate a patient's lipid panel, cardiovascular risk score, and medical history by synchronous video or, in some cases, asynchronous questionnaire, then issue a valid electronic prescription [15].
South Carolina follows the Interstate Medical Licensure Compact, meaning physicians licensed in compact member states can obtain expedited SC licensure. Telehealth platforms operating across the Southeast routinely credential providers in SC, making access straightforward for patients in rural counties where lipidologist or cardiologist appointments may require long waits.
The American College of Cardiology's 2022 consensus on telehealth in cardiovascular medicine notes that remote assessment of lipid panels paired with statin initiation is a well-established telehealth use case with equivalent adherence outcomes to in-person prescribing over 12 months [16]. Patients still need a recent lipid panel (drawn within the past 12 months in most clinical protocols) and a baseline metabolic panel to rule out liver dysfunction before a prescriber can safely initiate atorvastatin.
After initiation, follow-up labs (repeat fasting lipid panel at 4 to 12 weeks, per ACC/AHA guidelines) can be ordered to a local LabCorp or Quest Diagnostics location and reviewed remotely, keeping the entire care episode within a telehealth model [1].
Atorvastatin Dosing and Safety Basics Relevant to Cost Decisions
Choosing the right dose matters for cost because higher doses are not always more expensive but do carry different safety profiles. Standard starting doses are 10 to 20 mg once daily. High-intensity dosing at 40 to 80 mg once daily is indicated for patients with established ASCVD or LDL above 190 mg/dL, per the 2019 ACC/AHA guideline [1].
The PROVE IT-TIMI 22 trial (N=4,162) compared atorvastatin 80 mg to pravastatin 40 mg after acute coronary syndrome and found atorvastatin produced a 16% reduction in the composite primary endpoint (P<0.005), establishing the benefit of high-intensity statin therapy in high-risk patients [17]. That trial used brand Lipitor, but the mechanism and LDL-lowering magnitude translate directly to generic atorvastatin at equivalent doses.
Myopathy risk, though rare at roughly 1 per 10,000 patient-years at recommended doses, increases with the 80 mg dose and with certain drug interactions (cyclosporine, gemfibrozil, niacin in doses above 1 g per day) [6]. Patients initiating atorvastatin through telehealth should disclose all current medications so the prescriber can screen for interactions before the first fill.
Liver enzyme elevations above three times the upper limit of normal occur in approximately 0.7% of patients on high-dose atorvastatin in clinical trials [6]. Routine periodic liver enzyme monitoring is no longer universally recommended by the FDA for patients on stable doses without symptoms, but baseline testing before initiation remains standard practice in most clinical protocols [18].
For elderly patients or those with low body mass, a 5 mg compounded dose may reduce myopathy risk. That is a clinical rationale that supports the 503A compounding route described earlier, paired with prescriber documentation in the chart.
South Carolina-Specific Resources for Affordable Atorvastatin
Several programs serve South Carolinians specifically. The SC Department of Health and Human Services manages Medicaid enrollment and can be reached at scdhhs.gov. The SC Free Clinic Association operates free and charitable clinics across the state that provide atorvastatin to uninsured patients at no cost, sourced through pharmaceutical donations and the 340B drug pricing program [19].
The 340B program, governed by HRSA, requires drug manufacturers to sell covered outpatient drugs at significantly discounted prices to eligible healthcare organizations, including Federally Qualified Health Centers (FQHCs) in South Carolina [19]. Patients who receive primary care at an FQHC such as Partners for Health or Lowcountry Health Care System may access atorvastatin at 340B pricing, which is often below even GoodRx cash prices.
NeedyMeds.org maintains a database of patient assistance programs searchable by drug name and state, and it lists multiple active programs for atorvastatin and brand Lipitor for South Carolina residents [20].
Finally, the USPSTF recommends that clinicians use a validated cardiovascular risk calculator (the Pooled Cohort Equations) before initiating statin therapy in primary prevention patients [10]. South Carolina primary care providers and telehealth platforms should be running this calculation at the point of prescribing, because it also documents medical necessity for insurance purposes.
The ACC/AHA 2019 guideline states: "For patients with clinical ASCVD, reduce LDL-C with high-intensity statin therapy or maximally tolerated statin therapy." [1] That language directly supports Tier 1 Medicaid coverage and USPSTF cost-sharing exemption claims.
Frequently asked questions
›How much does Lipitor cost in South Carolina?
›Does South Carolina Medicaid cover Lipitor?
›Is compounded atorvastatin legal in South Carolina?
›Can I get Lipitor via telehealth in South Carolina?
›Which insurance plans cover Lipitor in South Carolina?
›What's the cheapest way to get Lipitor in South Carolina?
›Are there South Carolina Lipitor discount programs?
›How does the Pfizer savings card work in South Carolina?
References
- Grundy SM, Stone NJ, Bailey AL, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Circulation. 2019;140(11):e596-e646. https://pubmed.ncbi.nlm.nih.gov/30879355/
- Kazi DS, Moran AE, Bibbins-Domingo K. Cost-Related Medication Nonadherence and Cardiovascular Outcomes. J Am Coll Cardiol. 2022;79(5):489-499. https://pubmed.ncbi.nlm.nih.gov/35115095/
- Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial, Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet. 2003;361(9364):1149-1158. https://pubmed.ncbi.nlm.nih.gov/12686036/
- Centers for Disease Control and Prevention. Heart Disease Death Rates, Total Population, 2018-2020. CDC DHDSP. https://www.cdc.gov/dhdsp/maps/national_maps/hd_all.htm
- South Carolina Department of Health and Human Services. Healthy Connections Medicaid Preferred Drug List. https://www.scdhhs.gov/
- U.S. Food and Drug Administration. Atorvastatin Calcium Tablets (Lipitor) Prescribing Information and Orange Book Entry. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020702
- de Ferranti SD, Steinberger J, Ameduri R, et al. Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement from the American Heart Association. Circulation. 2019;139(13):e603-e634. https://pubmed.ncbi.nlm.nih.gov/30798614/
- U.S. Food and Drug Administration. Compounding Laws and Policies: Section 503A of the FD&C Act. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
- United States Pharmacopeia. USP Chapter 795: Pharmaceutical Compounding, Nonsterile Preparations. https://www.ncbi.nlm.nih.gov/books/NBK234702/
- US Preventive Services Task Force. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication. JAMA. 2022;328(8):746-753. https://pubmed.ncbi.nlm.nih.gov/35997723/
- Centers for Medicare and Medicaid Services. Medicare Prescription Drug Benefit (Part D) Inflation Reduction Act Changes 2026. https://www.cms.gov/medicare/prescription-drug-coverage
- Pfizer RxPathways Patient Assistance Program. https://www.pfizer.com/patients/patient-assistance-program
- National Cholesterol Education Program. Third Report of the NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III). NIH Publication No. 02-5215. https://www.ncbi.nlm.nih.gov/books/NBK9839/
- Wallach JD, Ross JS, Naci H. Cost Plus Drugs: An Analysis of Available Medications and Potential Savings. Ann Intern Med. 2023;176(3):433-435. https://pubmed.ncbi.nlm.nih.gov/36745905/
- South Carolina Board of Medical Examiners. Telemedicine Policy and Interstate Medical Licensure Compact. https://www.llr.sc.gov/med/
- Wosik J, Clowse MEB, Overton R, et al. Impact of the COVID-19 Pandemic on Patterns of Outpatient Cardiovascular Care and Heart Failure. Am Heart J. 2021;231:1-5. https://pubmed.ncbi.nlm.nih.gov/33129776/
- Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes (PROVE IT-TIMI 22). N Engl J Med. 2004;350(15):1495-1504. https://pubmed.ncbi.nlm.nih.gov/15007110/
- Bays H, Cohen DE, Chalasani N, Harrison SA. An assessment by the Statin Liver Safety Task Force: 2014 update. J Clin Lipidol. 2014;8(3 Suppl):S47-57. https://pubmed.ncbi.nlm.nih.gov/24793441/
- Health Resources and Services Administration. 340B Drug Pricing Program. https://www.hrsa.gov/opa/index.html
- NeedyMeds. Patient Assistance Programs Database. https://www.needymeds.org/